મેડપ્લસ હેલ્થ સર્વિસ શેર કિંમત

Healthcare Supplies company Medplus Health Services announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: In Q4FY26, the company reported Rs 18,643.85 million, a growth of 23.50% YoY compared to Rs 15,096.09 million in Q4FY25 and a growth of 3.23% QoQ from Rs 18,061.18 million in Q3FY26. For FY26, revenue was Rs 68,924.66 million, up 12.33% from Rs 61,360.53 million in FY25. Total Income: For Q4FY26, total income stood at Rs 18,849.80 million, representing a YoY increase of 23.57% from Rs 15,254.01 million and a QoQ increase of 3.32% from Rs 18,243.59 million. Annual total income reached Rs 69,637.90 million in FY26 compared to Rs 61,846.69 million in FY25. Profit Before Tax (PBT): The company recorded a PBT of Rs 803.42 million in Q4FY26, showing a YoY growth of 31.46% from Rs 611.16 million and a QoQ growth of 9.63% from Rs 732.87 million. For FY26, PBT grew by 50.22% to Rs 2,753.30 million from Rs 1,832.89 million in FY25. Profit After Tax (PAT): PAT for Q4FY26 was Rs 639.73 million, an increase of 24.65% YoY from Rs 513.20 million and a 10.70% increase QoQ from Rs 577.88 million. For FY26, PAT increased by 46.18% to Rs 2,196.06 million from Rs 1,502.33 million in FY25. Earnings Per Share (EPS): Basic EPS stood at Rs 5.33 for Q4FY26 compared to Rs 4.32 in Q4FY25. The annual Basic EPS for FY26 was Rs 18.33 compared to Rs 12.57 in FY25. Standalone Financial Highlights: Revenue from Operations: For Q4FY26, revenue reached Rs 2,480.36 million, up 22.94% YoY from Rs 2,017.51 million and up 11.23% QoQ from Rs 2,230.01 million. Annual revenue for FY26 stood at Rs 8,605.66 million compared to Rs 7,130.97 million in FY25. Total Income: Q4FY26 total income was Rs 2,505.22 million, showing a YoY growth of 22.56% from Rs 2,044.02 million and a QoQ growth of 11.00% from Rs 2,256.98 million. FY26 annual total income was Rs 8,713.32 million against Rs 7,220.32 million in FY25. Profit Before Tax (PBT): PBT in Q4FY26 was Rs 230.56 million, a growth of 28.72% YoY from Rs 179.12 million and 5.64% QoQ from Rs 218.26 million. Annual PBT for FY26 grew by 62.54% to Rs 831.73 million from Rs 511.72 million in FY25. Profit After Tax (PAT): PAT for Q4FY26 was Rs 166.72 million, up 19.24% YoY from Rs 139.82 million and 0.58% QoQ from Rs 165.76 million. Annual PAT for FY26 was Rs 624.12 million compared to Rs 403.35 million in FY25. Business Highlights: Segment Performance: Retail: Segment revenue grew to Rs 18,289.76 million from Rs 14,811.57 million. Segment results (profit) increased to Rs 705.23 million from Rs 551.57 million. Diagnostic Services: Segment revenue grew to Rs 347.80 million from Rs 280.83 million. The segment turned profitable with a result of Rs 9.64 million compared to a loss of Rs 9.04 million in the previous year's quarter. Others: Segment revenue was Rs 6.29 million compared to Rs 3.69 million. Segment result was a profit of Rs 4.29 million against Rs 2.45 million YoY. Share Allotment: The Board approved the allotment of 82,419 Equity Shares of face value Rs 2/- each under the MedPlus Employees Stock Option Plan, 2021. This increased the paid-up equity share capital from Rs 24,01,09,284 to Rs 24,02,74,122. IPO Proceeds Utilization: As of March 31, 2026, the company has fully utilized the IPO proceeds. Rs 4,671.70 million was invested in its subsidiary, Optival Health Solutions Private Limited, for working capital requirements, and Rs 1,117.63 million was used for general corporate purposes. Labour Code Impact: Due to the notification of 'New Labour Codes' effective November 21, 2025, the company's defined benefit obligation and defined benefit contribution increased by Rs 34.26 million and Rs 31.06 million respectively for the year ended March 31, 2026. Leadership Changes: The company noted the completion of tenure for Mr. Madhavan Ganesan and Mr. Murali Sivaraman as Non-Executive Independent Directors effective June 10, 2026. Mr. Ajit Pandurang Rangnekar and Mr. Mohankrishna Reddy Arvabumi were appointed as Additional Directors (Non-Executive Independent) effective May 20, 2026. Result PDF

• ટ્રેન્ડલાઇન
• 2 અઠવાડિયા 1 દિવસ પહેલાં

માર્ચ ક્વાર્ટર (Q4FY26) માં, મેડપ્લસ હેલ્થે એક વર્ષ પહેલાં 51.32 કરોડની તુલનામાં 63.97 કરોડનો ચોખ્ખો નફો નોંધાવ્યો, જે 24.6 ટકા વધ્યો

• બિઝનેસ સ્ટાન્ડર્ડ
• 2 અઠવાડિયા 1 દિવસ પહેલાં

હેલ્થકેર સપ્લાય કંપની મેડપ્લસ હેલ્થ સર્વિસે Q3FY26 પરિણામોની આવકની જાહેરાત કરી: Q3FY25 દરમિયાન ₹ 15,614.46 મિલિયન સામે ₹ 18,061.18 મિલિયન, ફેરફાર 16%. પીબીટી: Q3FY25 દરમિયાન ₹ 566 મિલિયન સામે ₹ 732.87 મિલિયન, 29% બદલો. પીએટી: Q3FY25 દરમિયાન ₹ 458.7 મિલિયન સામે ₹ 577.88 મિલિયન, 26% બદલો. ઇપીએસ: Q3FY26 માટે 4.82. પરિણામની PDF

• ટ્રેન્ડલાઇન
• 4 મહિના પહેલાં